Proprietary AI analyst is now available
- Public Comps
- Oxford Nanopore Technologies
Oxford Nanopore Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Oxford Nanopore Technologies and similar public comparables like MicroPort Scientific, UFP Technologies, Heron Neutron Medical, Draegerwerk and more.
Oxford Nanopore Technologies Overview
About Oxford Nanopore Technologies
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Founded
2005
HQ

Employees
1.3K
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialOxford Nanopore Technologies Financials
Oxford Nanopore Technologies reported last 12-month revenue of $329M and negative EBITDA of ($99M).
In the same LTM period, Oxford Nanopore Technologies generated $200M in gross profit, ($99M) in EBITDA losses, and had net loss of ($173M).
Revenue (LTM)
Oxford Nanopore Technologies P&L
In the most recent fiscal year, Oxford Nanopore Technologies reported revenue of $301M and EBITDA of ($116M).
Oxford Nanopore Technologies is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (39%), and net margin of (65%).
Financial data powered by Morningstar, Inc.
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Oxford Nanopore Technologies' stock price is $1.81.
Oxford Nanopore Technologies share price decreased by 6.3% in the last 30 days, and by 1.3% in the last year.
Oxford Nanopore Technologies has an EPS (earnings per share) of $-0.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | -1.4% | -6.3% | 20.1% | -1.3% | $-0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOxford Nanopore Technologies Valuation Multiples
Oxford Nanopore Technologies trades at 4.5x EV/Revenue multiple, and (14.8x) EV/EBITDA.
EV / Revenue (LTM)
Oxford Nanopore Technologies Financial Valuation Multiples
As of June 5, 2026, Oxford Nanopore Technologies has market cap of $2B and EV of $1B.
Oxford Nanopore Technologies has a P/E ratio of (10.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Oxford Nanopore Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Oxford Nanopore Technologies Margins & Growth Rates
Oxford Nanopore Technologies grew revenue by 23% but EBITDA decreased by 34% in the last fiscal year.
In the most recent fiscal year, Oxford Nanopore Technologies reported gross margin of 59%, EBITDA margin of (39%), and net margin of (65%).
Oxford Nanopore Technologies Margins
Oxford Nanopore Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Oxford Nanopore Technologies Operational KPIs
Oxford Nanopore Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Oxford Nanopore Technologies' Rule of 40 is 2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Oxford Nanopore Technologies' Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Oxford Nanopore Technologies Competitors
Oxford Nanopore Technologies competitors include MicroPort Scientific, UFP Technologies, Heron Neutron Medical, Draegerwerk, MicroPort, Embla Medical, Syngene, 4DMedical, Pulse Biosciences and Generate Biomedicines.
Most Oxford Nanopore Technologies public comparables operate across Life Sciences Tools, Medical Devices, BioTech, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.3x | 2.2x | 16.0x | 13.4x | |||
| 3.1x | 3.0x | 15.5x | 14.9x | |||
| 4492.5x | - | (105.0x) | - | |||
| 0.4x | 0.4x | 3.8x | 3.7x | |||
| 7.5x | 7.0x | 13.8x | 13.0x | |||
| 2.5x | 2.3x | 12.1x | 11.6x | |||
| 4.4x | 4.3x | 17.2x | 17.0x | |||
| 395.7x | 280.9x | (92.1x) | (28.5x) | |||
This data is available for Pro users. Sign up to see all Oxford Nanopore Technologies competitors and their valuation data. Start Free Trial | ||||||
Oxford Nanopore Technologies VC Funding History
Before going public, Oxford Nanopore Technologies raised $1B in total equity funding, across 11 rounds.
Last private valuation of Oxford Nanopore Technologies was $3B, after raising $277M in May 2021 from IP Group, M&G Investments, Nikon, and 2 other investors.
Oxford Nanopore Technologies Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Oxford Nanopore Technologies
| When was Oxford Nanopore Technologies founded? | Oxford Nanopore Technologies was founded in 2005. |
| Where is Oxford Nanopore Technologies headquartered? | Oxford Nanopore Technologies is headquartered in United Kingdom. |
| How many employees does Oxford Nanopore Technologies have? | As of today, Oxford Nanopore Technologies has over 1K employees. |
| Who is the CEO of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' CEO is Gurdial Sanghera. |
| Is Oxford Nanopore Technologies publicly listed? | Yes, Oxford Nanopore Technologies is a public company listed on London Stock Exchange. |
| What is the stock symbol of Oxford Nanopore Technologies? | Oxford Nanopore Technologies trades under ONT ticker. |
| When did Oxford Nanopore Technologies go public? | Oxford Nanopore Technologies went public in 2021. |
| Who are competitors of Oxford Nanopore Technologies? | Oxford Nanopore Technologies main competitors include MicroPort Scientific, UFP Technologies, Heron Neutron Medical, Draegerwerk, MicroPort, Embla Medical, Syngene, 4DMedical, Pulse Biosciences, Generate Biomedicines. |
| What is the current market cap of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' current market cap is $2B. |
| What is the current revenue of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' last 12 months revenue is $329M. |
| What is the current revenue growth of Oxford Nanopore Technologies? | Oxford Nanopore Technologies revenue growth (NTM/LTM) is 23%. |
| What is the current EV/Revenue multiple of Oxford Nanopore Technologies? | Current revenue multiple of Oxford Nanopore Technologies is 4.5x. |
| Is Oxford Nanopore Technologies profitable? | No, Oxford Nanopore Technologies is not profitable. |
| What is the current EBITDA of Oxford Nanopore Technologies? | Oxford Nanopore Technologies has negative EBITDA and is not profitable. |
| What is Oxford Nanopore Technologies' EBITDA margin? | Oxford Nanopore Technologies' last 12 months EBITDA margin is (30%). |
| What is the current EV/EBITDA multiple of Oxford Nanopore Technologies? | Current EBITDA multiple of Oxford Nanopore Technologies is (14.8x). |
| What is the current FCF of Oxford Nanopore Technologies? | Oxford Nanopore Technologies' last 12 months FCF is ($111M). |
| What is Oxford Nanopore Technologies' FCF margin? | Oxford Nanopore Technologies' last 12 months FCF margin is (34%). |
| What is the current EV/FCF multiple of Oxford Nanopore Technologies? | Current FCF multiple of Oxford Nanopore Technologies is (13.3x). |
| How many companies Oxford Nanopore Technologies has acquired to date? | Oxford Nanopore Technologies hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Oxford Nanopore Technologies has invested to date? | Oxford Nanopore Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Oxford Nanopore Technologies
Lists including Oxford Nanopore Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.